Adult patients (aged ≥18 years) with asthma who were receiving either salbutamol pMDI (Ventolin®, Allen & Hanburys Ltd) or terbutaline Turbuhaler® (Bricanyl®, Astra Pharmaceuticals Ltd) bronchodilator ...

In both the Easyhaler DPI and Evohaler pMDI cohorts, 98.3% of patients with asthma recovered FEV1 to at least -10% of baseline after their last treatment post MC test. Investigators sought to ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children aged 5 to 15, an international team found the combined treatment to be ...

Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-colored inhaler (or "puffer"). This kind of "rescue inhaler" brings quick relief from ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomised controlled trial to investigate the use of a ...

Patients who switched from a pressurized metered dose inhaler (pMDIs) to a dry powder inhaler (DPI) halved their carbon footprints while still maintaining good asthma control, a post-hoc analysis of ...

Lung deposition of radiolabeled Ventoline (chlorofluorocarbon salbutamol, GlaxoSmithKline) pressurized metered-dose inhaler administered via the three spacer devices was measured in an animal “infant” ...

Inhalers have been key to asthma management since the 1950s. The most common, salbutamol, comes in a familiar blue-coloured inhaler (or “puffer”). This kind of “rescue inhaler” brings quick relief ...